FDA NDC Directory · JSON-LD · Markdown

Liothyronine sodium

NDC 68382-583 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214803
Dosage form / routeTABLET · ORAL
Active ingredientsLIOTHYRONINE SODIUM (25 ug/1)
Marketing started20210201
Package count2

External sources

Source: openFDA. Public-domain (CC0).